Perimenopause discharge, yeast infections and UTIs: what's normal and what actually helps

Is discharge in perimenopause normal?

Usually, yes. Healthy discharge is mostly clear mucus made by the cervix and the vaginal walls. MedlinePlus, the NIH's patient library, notes it can turn white or yellow once it dries on your underwear.

Before perimenopause, the amount follows your cycle. It gets wetter and stretchier around ovulation, then thicker or drier afterward.

Perimenopause scrambles that rhythm. Estrogen does not fall in a straight line. It swings, and some months it climbs higher than it did in your 30s. A high-estrogen month can bring more wet, slippery discharge than you are used to. A low month can leave you feeling dry.

Brown discharge is usually old blood. Spotting between periods is common when cycles turn irregular, and our guide to erratic perimenopause periods explains what is typical.

What GSM is, and why it changes discharge

As estrogen keeps falling, the lining of the vagina gets thinner, drier and more fragile. The Menopause Society, ACOG and the American Urological Association call this genitourinary syndrome of menopause, or GSM. The older name was vaginal atrophy.

GSM is more than dryness. It covers burning, irritation, discharge and pain with sex. It also covers bladder symptoms such as urgency, burning when you pee and repeat urinary tract infections. The 2025 AUA guideline notes these changes can start in perimenopause, not only after your last period.

Acid balance is a big part of the story. Doctors measure it as pH, a scale where lower numbers mean more acidic. A healthy vagina stays acidic, at a pH of 4.5 or below.

That acidity comes from lactobacilli, friendly bacteria that feed on sugar stored in estrogen-rich vaginal cells. They turn it into lactic acid. With less estrogen there is less food, fewer lactobacilli and a higher pH. The Menopause Society notes the pH in GSM is typically above 5.

A less acidic vagina lets other bacteria move in, including the gut bacteria behind most bladder infections. That one change links the discharge, the odor and the UTIs.

GSM is very common. The Menopause Society puts it at 27% to 84% of women after menopause, depending on the study. Unlike hot flashes, which usually fade, it tends to get worse over time without treatment. It sits alongside the other changes in our perimenopause symptoms list.

Perimenopause watery discharge: the usual causes

Thin, watery discharge has a short list of usual suspects. Most are harmless, and one is worth a test.

• An estrogen surge. Wet, clear discharge around ovulation can be heavier in a high-estrogen month. It has no odor and causes no itch.
• Thinning tissue from GSM. The Menopause Society lists discharge among the most common GSM symptoms. It tends to come with dryness during sex, burning or a raw feeling.
• Bacterial vaginosis. Called BV for short, this is an overgrowth of mixed bacteria that crowds out the lactobacilli. The CDC describes a thin, milky discharge with a fishy odor.
• Small bladder leaks. A leak when you cough, laugh or rush to the bathroom can feel like watery discharge. Urge leaks are part of the GSM picture too.

One rare cause is worth knowing about. The American Cancer Society notes that discharge without visible blood can sometimes be a sign of endometrial cancer, the cancer of the uterine lining. It asks women past menopause to report any spotting or unusual discharge.

Perimenopause yellow discharge: what it can mean

A pale yellow mark on your underwear is often normal discharge that has dried in the air. A new, darker yellow discharge, or one with odor, itching or burning, points to a cause worth naming.

• Atrophic vaginitis. This is inflammation of thinned, low-estrogen tissue, one form of GSM. The Menopause Society notes it can cause brown or yellow discharge that sometimes smells. It is not an infection, and it responds to treatment of the tissue itself, such as vaginal estrogen.
• Trichomoniasis. Called trich for short, this sexually transmitted infection is caused by a parasite. The CDC describes a yellow-green, often bad-smelling discharge with irritation. Most people with trich have few or no symptoms, and it does not fade with age the way some infections do. It is treated with prescription pills, and partners need treatment too.
• Cervicitis. This is inflammation of the cervix, most often from chlamydia or gonorrhea. MedlinePlus describes gray, white or yellow discharge, and bleeding after sex or between periods. It often causes no symptoms at all.
• Desquamative inflammatory vaginitis. This rare inflammatory condition is most common around and after menopause. The Merck Manual describes heavy, pus-like yellow or green discharge with redness, burning and pain with sex. It needs an exam to diagnose, and it is treated with prescription vaginal medicine.

These look alike at home and very different under a microscope. One visit with a swab and a quick pH test usually sorts them out.

If you are dating again after a divorce or a long gap, keep infections on the list. Sexually transmitted infections do not check your age, and the CDC notes trich stays common in older women.

Hormones or infection? How GSM, yeast, BV and trich differ

The CDC's 2021 treatment guidelines name three infections behind most vaginal discharge: BV, trichomoniasis and yeast. GSM is the hormonal look-alike. Here is how they usually compare, based on the CDC guidelines, ACOG and The Menopause Society.

• GSM. Discharge is thin, watery or yellowish, and sometimes scant. Odor is usually mild. The main feelings are dryness, burning and pain with sex. The pH is high, often above 5.
• Yeast infection. Discharge is thick, white and lumpy, like cottage cheese. There is little or no odor. Itching and soreness of the vulva are the main complaints. The pH stays normal, at 4.5 or below.
• Bacterial vaginosis. Discharge is thin, milky and gray-white. A fishy odor is the classic sign. Itching is usually mild or absent. The pH is above 4.5.
• Trichomoniasis. Discharge can be yellow-green and bad-smelling, with burning or swelling of the vulva. Many women have no symptoms. The pH is above 4.5.

The overlap is large, and guessing goes wrong often. The CDC warns that even women who have had a yeast infection diagnosed before are not reliably able to diagnose the next one. Using over-the-counter yeast cream for the wrong problem can delay the right treatment.

There is a twist after menopause. The Menopause Society notes that vaginal bacteria in many older women look like BV on a test, with a high pH and a mix of bacteria. Often that reflects a loss of lactobacilli rather than an infection. For many of these women, it says, vaginal estrogen works better than another round of antibiotics.

That is how women end up treated one infection at a time for years. Each course clears the symptom for a while, and the thin tissue underneath stays the same.

Why perimenopause yeast infections keep coming back

Yeast likes estrogen. The yeast called Candida feeds on glycogen, a sugar that estrogen stores in vaginal cells. That is why yeast infections become less common after menopause, when glycogen runs low.

Estrogen given as treatment can bring yeast back. In a 2011 study of women past menopause, published in the Journal of Lower Genital Tract Disease, yeast grew in cultures from 48.5% of 70 women on hormone therapy, compared with 3% of 79 women not taking it.

Perimenopause sits in the middle, and several triggers can stack up:

• Estrogen peaks. The high months of perimenopause feed yeast the way your younger cycles did.
• Hormone therapy. The Menopause Society lists yeast infections among the side effects reported with vaginal estrogen.
• Antibiotics. Each course for a UTI or a sinus infection also knocks back the lactobacilli that keep yeast in check.
• Diabetes. The CDC and MedlinePlus list it as a risk factor, and poorly controlled blood sugar raises the risk further.
• SGLT2 diabetes drugs. The FDA labels for Jardiance and Farxiga list genital yeast infections among their common side effects.
• Steroid medicines. The CDC lists corticosteroids among the drugs that make yeast more likely.

Itching is not always yeast. GSM causes itching and burning. So do skin conditions such as lichen sclerosus, and irritation from scented soaps, wipes or pads. If you also itch in other places, our guide to perimenopause skin sensations covers that side of things.

The CDC calls yeast recurrent at three or more symptomatic infections in less than a year. That affects fewer than 5% of women. Most of them have no obvious trigger, according to the CDC. Recurrent yeast calls for a culture to identify the exact species and a longer treatment plan, not another tube from the pharmacy.

Perimenopause and urinary tract infections: why UTIs return

A urinary tract infection, or UTI, is usually a bladder infection. It causes burning when you pee, urgent and frequent trips to the bathroom, and sometimes cloudy urine.

Estrogen protects the bladder in two ways. It keeps lactobacilli in charge of the vagina, so gut bacteria such as E. coli struggle to settle near the urethra, the short tube that carries urine out. The urethra and bladder also have estrogen receptors and thin out as levels fall. MedlinePlus lists menopause itself as a risk factor for UTIs.

Sex can push bacteria toward the urethra, which is why some women notice UTIs following sex more often now. Thin, dry tissue makes that easier.

The Menopause Society defines recurrent UTIs as two infections confirmed by urine culture in six months, or three in a year. The AUA guideline uses a similar definition.

Vaginal estrogen is the first-line fix

The American Urological Association updated its recurrent UTI guideline in 2025. It says that in perimenopausal and postmenopausal women with recurrent UTIs, clinicians should recommend vaginal estrogen to lower the risk of future infections, unless there is a reason not to. That is a moderate recommendation backed by moderate-quality evidence. The 2025 AUA guideline on GSM says the same.

The evidence goes back decades. In a 1993 randomized trial, women using a vaginal cream of estriol, a milder estrogen, averaged 0.5 UTIs a year, compared with 5.9 a year on placebo. The cream restored lactobacilli and lowered vaginal pH.

Cranberry, D-mannose, probiotics and the rest

The 2025 AUA update rates the popular options more clearly than before:

• Cranberry. Clinicians should offer it as a prevention option, a moderate recommendation. Products vary a lot in strength.
• D-mannose. The AUA now says it may not work on its own. In a 2024 trial of 598 women, 51.0% on D-mannose needed care for a suspected UTI, compared with 55.7% on placebo, a gap too small to count.
• Probiotics. The evidence is too thin to recommend them for preventing UTIs. The AUA's GSM guideline also says supplements are not supported for treating GSM.
• More water. If you drink less than about 50 ounces a day, drinking more is a reasonable option, with a weaker recommendation.
• Methenamine. This non-antibiotic prescription pill may be offered for prevention.
• Preventive antibiotics. A low-dose antibiotic is an option after you and your clinician weigh the risks, including resistance and yeast infections.

Ask for a urine culture each time. The AUA says each episode should get a urinalysis and culture before treatment starts. A culture confirms the infection and shows which antibiotic will work. A string of positive cultures is also what defines recurrent UTIs.

Perimenopause urinary symptoms: is it a UTI or GSM?

Many women in their 40s and 50s get UTI-like symptoms with no infection behind them. The culture comes back negative, yet the burning and urgency stay.

GSM is a common reason. Thin tissue around the urethra can cause urgency, frequent peeing, waking at night to go and burning with urination. The 2025 AUA update says that when UTI symptoms persist after an infection has cleared, clinicians should look for another cause.

Some clues point toward GSM rather than a fresh infection:

• Negative cultures. Symptoms keep coming, but the lab finds no bacteria.
• Dryness or pain with sex shows up alongside the bladder symptoms.
• Burning at the opening rather than deep in the bladder.
• Symptoms between infections that never fully go away.
• Urgency with leaks, where you can't quite make it to the bathroom.

A true UTI tends to start suddenly, with strong burning and urgency, sometimes cloudy or bloody urine, and a positive culture.

Vaginal estrogen helps the bladder side of GSM too. The 2025 AUA guideline says clinicians may offer it to women with GSM and an overactive bladder. The Menopause Society calls a first trial of vaginal estrogen sensible when both vaginal and urinary symptoms are present. If the bladder symptoms are not better after three months, it suggests moving on to other proven bladder treatments.

A pelvic floor physical therapist can help with leaks, urgency and pain with sex. The AUA lists referral as an option for women with GSM and pelvic floor problems.

Systemic hormone therapy is a different story for leaks. Systemic means pills, patches or gels that reach the whole body. The Menopause Society notes that in trials, systemic estrogen made urinary incontinence slightly worse, while vaginal estrogen improved it. If leaks are your main bladder problem, that is worth raising before you choose a type.

Vaginal dryness: choosing a water-based lubricant for menopause

Lubricants and moisturizers do different jobs. A lubricant eases friction during sex and wears off soon after. A vaginal moisturizer is used regularly, a few times a week, whether or not you have sex. It aims to ease everyday dryness.

The Menopause Society calls both first-line for mild symptoms, and says over-the-counter products are enough for most women with mild GSM. The 2025 AUA guideline recommends them alone or alongside other treatment.

• Water-based lubricant. It is easy to wash off and safe with condoms and toys. It can dry out during sex, and some brands are very concentrated. Lab studies found that very concentrated, or high-osmolality, water-based products can damage vaginal cells. The World Health Organization advises an osmolality under 1,200 mOsm/kg, though few labels list it.
• Silicone-based lubricant. It lasts longer and is safe with latex condoms. In one small study of breast cancer survivors, it brought more comfort than a water-based one.
• Oil-based lubricant. Coconut oil, olive oil and petroleum jelly feel slick, but oils can weaken latex condoms. The Menopause Society also cites one study linking petroleum jelly to more BV, and oils to more yeast.
• Vaginal moisturizer. Products such as Replens or hyaluronic acid gels hold water in the tissue. Small trials found hyaluronic acid eased dryness about as well as vaginal estrogen, but no better than other moisturizers.

Some ingredients are worth skipping if you sting easily. The Menopause Society notes there is very little safety data on flavored, sugary or warming lubricants, or on preservatives such as propylene glycol and parabens. The AUA advises avoiding irritants and harsh cleansers altogether. That includes douches, which the CDC links to more BV.

A simple test helps. The Menopause Society suggests trying a new product on a small patch of skin for 24 hours before using it inside the vagina.

If dryness is mostly hurting your sex life or your desire, our guide to perimenopause and libido goes deeper into that side.

Vaginal estrogen and other treatments that fix the cause

Lubricants cover the symptom. Prescription treatments rebuild the tissue, restore lactobacilli and bring the pH back down. The 2025 AUA guideline gives low-dose vaginal estrogen a strong recommendation for GSM.

• Vaginal cream. Estrace contains estradiol and Premarin contains conjugated estrogens, and generic estradiol cream is available too. It goes in with an applicator and can also be smoothed onto the vulva. The dose is less exact than with other forms.
• Vaginal tablet or insert. Vagifem and its generic Yuvafem are small tablets placed with an applicator. Imvexxy is a soft insert placed with a finger. Both are tidy and pre-measured.
• Vaginal ring. Estring is a soft ring that stays in place for three months at a time. It is not the same as Femring, a higher-dose ring that treats hot flashes too.
• Vaginal DHEA. Intrarosa is a nightly insert of prasterone, a hormone the vaginal cells turn into estrogen and male-type hormones locally. The FDA approved it for painful sex caused by menopause. The Menopause Society notes vaginal discharge was its most common side effect.
• Ospemifene. Osphena is a daily pill that acts like estrogen on vaginal tissue. It is approved for painful sex and vaginal dryness from menopause. Its label carries a boxed warning about endometrial cancer and stroke.

Low-dose vaginal estrogen stays mostly where you put it. The Menopause Society reports that the tablets, inserts and ring keep blood estrogen within the normal range for a woman after menopause. Large observational studies of tens of thousands of women found no rise in heart disease or cancer with vaginal estrogen.

You do not need to add a progestogen, the hormone that protects the uterine lining. The Menopause Society advises against routine checks of the uterine lining for low-risk women. The AUA's 2025 guideline goes further and says clinicians should not run those checks just because you use vaginal estrogen, DHEA or ospemifene.

Relief usually starts within a few weeks, and full benefit can take about 12 weeks. GSM tends to return when treatment stops, so most women stay on it. Some notice extra discharge, a yeast infection or mild spotting at first. Our guide to HRT side effects covers what is common.

Why vaginal estrogen is losing its boxed warning

For decades, vaginal estrogen came with the same boxed warning as hormone pills. A boxed warning is the strongest alert on a US drug label. The Menopause Society noted that many women never started treatment after reading it.

On November 10, 2025, the FDA asked makers of all menopause hormone products to remove the heart disease, breast cancer and dementia statements from the box. It also asked them to drop the endometrial cancer statement, except on systemic estrogen-only products. For low-dose vaginal estrogen, that removes the whole box.

The first six updated labels were approved on February 12, 2026, including Estring. Its current label carries no boxed warning. Other vaginal products are still updating, so an older box may still appear on some packages for now.

If you have had breast cancer

ACOG's 2021 Clinical Consensus on this question starts with non-hormone options, such as lubricants and moisturizers. If they fail, it says low-dose vaginal estrogen may be used after a talk about risks and benefits, including for women taking tamoxifen. For women on aromatase inhibitors, a common type of breast cancer pill, the decision is shared with the oncologist.

The 2025 AUA guideline says there is no evidence linking low-dose vaginal estrogen to developing breast cancer. For survivors, it supports vaginal estrogen as a shared decision with the cancer team. Intrarosa has not been studied in women with a history of breast cancer, and the Osphena label says it should not be used after breast cancer.

Does regular HRT fix dryness, discharge and UTIs?

Often it helps a lot, but not always completely. Systemic hormone therapy treats hot flashes and reaches vaginal tissue too. The Menopause Society says women on systemic therapy usually get good relief from vaginal symptoms, and low-dose vaginal estrogen can be added if they don't.

The 2025 AUA guideline makes the add-on explicit. For women on systemic estrogen who still have GSM, clinicians should offer vaginal estrogen or vaginal DHEA as well. Using both is common and expected.

If dryness, discharge or bladder symptoms are your only complaints, vaginal treatment is the preferred choice. It treats the tissue directly with far less hormone reaching the rest of your body. If hot flashes and poor sleep are part of the picture too, systemic therapy plus a vaginal product may cover everything.

Our guide to how HRT works explains the different types. For every option side by side, including non-hormone ones, see our overview of menopause treatment options.

Where to get vaginal estrogen, and what it costs

Any OB-GYN, family doctor or nurse practitioner can prescribe vaginal estrogen. Generic estradiol vaginal cream exists, and insurance usually covers it. Our breakdown of estradiol cream cost shows what the brand and generic versions cost with and without insurance.

Some menopause telehealth services build vaginal cream into their plans. Inner Balance includes Oestra, its vaginal cream with estradiol and progesterone, in every plan. It costs about $200 a month for the first six months, then about $100 a month. Oestra is compounded, meaning a licensed pharmacy mixes it to order, so it is not an FDA-approved finished product. Our Inner Balance review covers the refund terms and the reviews.

Winona sells a vaginal estrogen cream for about $90 a month, with no visit fee. Its creams are compounded in Winona's own pharmacies, while its estrogen patch, estrogen tablets and progesterone capsules are FDA-approved. Our Winona review lists the states it covers.

When to see a doctor about discharge or urinary symptoms

Most of these changes can wait for a routine visit. The signs below come from MedlinePlus, and they deserve a prompt call.

• Fever, chills, back or side pain, or vomiting with UTI symptoms, which can signal a kidney infection.
• Blood in your urine.
• Any bleeding after menopause, or bleeding after sex or between periods that you can't explain.
• Discharge with fever or pain in your pelvis or belly.
• A sudden change in the amount, color, odor or texture of your discharge.
• Blisters or sores on the vulva or in the vagina.
• A possible sexually transmitted infection, or a new partner and new symptoms.
• Your first-ever yeast symptoms, or yeast treatment from the pharmacy that did not work.
• UTI symptoms that return soon after antibiotics.
• Symptoms that get worse, or last longer than 1 week despite home care.

If you are not sure whether to book a gynecologist, a urologist or your family doctor, our guide to finding perimenopause care explains who handles what. Note when each infection happened and whether a culture was done. That short list often gets you to the GSM conversation faster.